[1]
Sukhjinder Chauhan et al. 2023. Euglycemic Ketoacidosis Secondary Due to SGLT2 Inhibitors. Novel Research Aspects in Medicine and Medical Science Vol. 7. (Oct. 2023), 25–33. DOI:https://doi.org/10.9734/bpi/nramms/v7/19902D.